from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1163/narJ

LFCtreatmentdescriptionclass of inhibitor

-0.629

Amikacinug/mL Amikacintranslation

-1.262

Cap5-10ug/mL Capreomycintranslation

-1.208

Rox10-50 ug/mL Roxithromycintranslation

-0.848

SM2-5 ug/mL Streptomycintranslation

-2.168

Tet5-10 ug/mL Tetracyclinetranslation

-0.927

Rif0.2-5ug/mL Rifampicintranscription

-0.005

Rifp0.1-0.5ug/mL Rifapentinetranscription

3.271

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.751

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.151

CPZ10-50 ug/mL Chlorpromazinerespiration

1.004

Clofazimine10-13 ug/mL Clofaziminerespiration

0.678

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.275

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.952

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.422

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.022

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.400

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.304

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

2.206

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.380

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.422

KCN5-20 ug/mL Potassium cyaniderespiration

0.281

NaN30.2-2 mM Sodium aziderespiration

-0.071

Nigericin50 uM Nigericinrespiration

-0.136

TRC10-150 ug/mL Triclosanrespiration

-0.500

TRZ10-25 ug/mL Thioridazinerespiration

-0.711

Valinomycin0.5-10 uM Valinomycinrespiration

0.359

ZnSO42 mM ZnSO4respiration

-0.471

menadione6-10 ug/mL Menadionerespiration

0.066

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.257

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.407

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.032

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.230

NRP_1Non-replicating persistence stage 1dosRassociated

-0.564

Amp0.2mg/mL AmpicillincellWall

-0.310

Cephalexin20-100 ug/mL CephalexincellWall

-0.251

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.534

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-1.020

EMB10-20 ug/mL EthambutolcellWall

-0.036

Eta12-40 ug/mL EthionamidecellWall

-0.537

INH0.2-0.4 ug/mL IsoniazidcellWall

0.101

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.700

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.270

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.698

BZA0.12 mg/mL BenzamidearomaticAmides

0.107

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.027

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.699

H2O24 mM hydrogen peroxideDNAdamaging

0.077

Levo10 ug/mL LevofloxacinDNAdamaging

-0.756

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.538

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.383

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.674

UVUV-irradiationDNAdamaging

0.005

ARP41-4 ug/mL Antitubercular compound ARP4?

0.195

Antimycin12.5-50 ug/mL Antimycin A?

0.241

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.194

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.273

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.515

PA8240.2-2 ug/mL PA-824?

0.732

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.322

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.585

Verapamil50 uM Verapamil?

0.427

mercaptoethanol2 mM 2-Mercaptoethanol?

0.977

methoxatin10-20 ug/mL Methoxatin?